CROCS INC (CROX)

US2270461096 - Common Stock

130.5  +5.36 (+4.28%)

After market: 130.5 0 (0%)

Fundamental Rating

7

CROX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 52 industry peers in the Textiles, Apparel & Luxury Goods industry. While CROX has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CROX. With these ratings, CROX could be worth investigating further for value investing!.



9

1. Profitability

1.1 Basic Checks

CROX had positive earnings in the past year.
CROX had a positive operating cash flow in the past year.
Each year in the past 5 years CROX has been profitable.
In the past 5 years CROX always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 16.59%, CROX belongs to the top of the industry, outperforming 94.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 49.81%, CROX belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 21.10%, CROX belongs to the best of the industry, outperforming 94.00% of the companies in the same industry.
CROX had an Average Return On Invested Capital over the past 3 years of 30.08%. This is significantly above the industry average of 10.62%.
The last Return On Invested Capital (21.10%) for CROX is well below the 3 year average (30.08%), which needs to be investigated, but indicates that CROX had better years and this may not be a problem.
Industry RankSector Rank
ROA 16.59%
ROE 49.81%
ROIC 21.1%
ROA(3y)25.34%
ROA(5y)24.04%
ROE(3y)1755.79%
ROE(5y)1093.13%
ROIC(3y)30.08%
ROIC(5y)27.47%

1.3 Margins

CROX has a better Profit Margin (19.80%) than 100.00% of its industry peers.
CROX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 26.43%, CROX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CROX has grown nicely.
CROX's Gross Margin of 56.16% is fine compared to the rest of the industry. CROX outperforms 72.00% of its industry peers.
CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.43%
PM (TTM) 19.8%
GM 56.16%
OM growth 3Y13.61%
OM growth 5Y32.68%
PM growth 3Y-3.95%
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y1.62%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CROX is creating value.
CROX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CROX has less shares outstanding
Compared to 1 year ago, CROX has an improved debt to assets ratio.

2.2 Solvency

CROX has an Altman-Z score of 3.92. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.92, CROX is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
The Debt to FCF ratio of CROX is 2.19, which is a good value as it means it would take CROX, 2.19 years of fcf income to pay off all of its debts.
CROX has a Debt to FCF ratio of 2.19. This is comparable to the rest of the industry: CROX outperforms 60.00% of its industry peers.
A Debt/Equity ratio of 1.08 is on the high side and indicates that CROX has dependencies on debt financing.
CROX has a Debt to Equity ratio of 1.08. This is amonst the worse of the industry: CROX underperforms 82.00% of its industry peers.
Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 2.19
Altman-Z 3.92
ROIC/WACC2.39
WACC8.83%

2.3 Liquidity

CROX has a Current Ratio of 1.76. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
CROX's Current ratio of 1.76 is on the low side compared to the rest of the industry. CROX is outperformed by 70.00% of its industry peers.
A Quick Ratio of 1.14 indicates that CROX should not have too much problems paying its short term obligations.
The Quick ratio of CROX (1.14) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.14

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.46% over the past year.
CROX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 55.01% yearly.
Looking at the last year, CROX shows a small growth in Revenue. The Revenue has grown by 6.29% in the last year.
Measured over the past years, CROX shows a very strong growth in Revenue. The Revenue has been growing by 29.49% on average per year.
EPS 1Y (TTM)8.46%
EPS 3Y55.01%
EPS 5YN/A
EPS Q2Q%15.71%
Revenue 1Y (TTM)6.29%
Revenue growth 3Y41.93%
Revenue growth 5Y29.49%
Sales Q2Q%6.16%

3.2 Future

The Earnings Per Share is expected to grow by 8.43% on average over the next years. This is quite good.
Based on estimates for the next years, CROX will show a small growth in Revenue. The Revenue will grow by 6.89% on average per year.
EPS Next Y7.19%
EPS Next 2Y8.07%
EPS Next 3Y7.71%
EPS Next 5Y8.43%
Revenue Next Year4.46%
Revenue Next 2Y5.07%
Revenue Next 3Y4.19%
Revenue Next 5Y6.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.49, the valuation of CROX can be described as reasonable.
86.00% of the companies in the same industry are more expensive than CROX, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 24.41. CROX is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 9.29, the valuation of CROX can be described as reasonable.
CROX's Price/Forward Earnings ratio is rather cheap when compared to the industry. CROX is cheaper than 90.00% of the companies in the same industry.
CROX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.59.
Industry RankSector Rank
PE 10.49
Fwd PE 9.29

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CROX is valued a bit cheaper than 68.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CROX is valued a bit cheaper than the industry average as 66.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.04
EV/EBITDA 8.19

4.3 Compensation for Growth

CROX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CROX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.46
PEG (5Y)N/A
EPS Next 2Y8.07%
EPS Next 3Y7.71%

0

5. Dividend

5.1 Amount

CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (7/26/2024, 7:23:35 PM)

After market: 130.5 0 (0%)

130.5

+5.36 (+4.28%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.92B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 10.49
Fwd PE 9.29
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.59%
ROE 49.81%
ROCE
ROIC
ROICexc
ROICexgc
OM 26.43%
PM (TTM) 19.8%
GM 56.16%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.76
Quick Ratio 1.14
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)8.46%
EPS 3Y55.01%
EPS 5Y
EPS Q2Q%
EPS Next Y7.19%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.29%
Revenue growth 3Y41.93%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y